Anatara Lifesciences LtdASX: ANR

Anatara Trial Update

· Issued by Anatara Lifesciences Ltd

Filed with ASX · · 2 pages · English

Key points:  Third Australian field trial terminated proactively  Target Animal Safety Study continues, with no adverse effects reported  Anatara remains on track to submit product registration dossier to the APVMA in Q3 2016 and launch Detach™ in Australia during 2017 th voluntarily terminated the third efficacy study in Australia, announced on 16 June 2016 for its lead product, Detach™, a non

Anatara Lifesciences Ltd on 6ix

Story so far

Earlier from Anatara Lifesciences

Later from Anatara Lifesciences

All Anatara Lifesciences news releases